FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Koukourakis

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michael I Koukourakis; Alexandra Giatromanolaki; Christos E Zois; Efthimios Sivridis
LC3 immunostaining pitfalls.
Alexandra Giatromanolaki; A L Harris; Michael I Koukourakis; ANASTASIOS KOUTSOPOULOS; K C Gatter; Efthimios Sivridis
Autophagy and hypoxia in colonic adenomas related to aggressive features.
Michael I Koukourakis; Efthimios Sivridis; Kevin C Gatter; Alexandra Giatromanolaki; Adrian L Harris
High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Koukourakis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael I Koukourakis; Alexandra Giatromanolaki; Christos E Zois; Efthimios Sivridis
LC3 immunostaining pitfalls.
Histopathology 2013;62(6):962-3.
2013: Alexandra Giatromanolaki; A L Harris; Michael I Koukourakis; ANASTASIOS KOUTSOPOULOS; K C Gatter; Efthimios Sivridis
Autophagy and hypoxia in colonic adenomas related to aggressive features.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2013;15(5):e223-30.
2013: Michael I Koukourakis; Efthimios Sivridis; Kevin C Gatter; Alexandra Giatromanolaki; Adrian L Harris
High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
Angiogenesis 2013;16(2):343-51.
2013: Alexandra Giatromanolaki; Adrian L Harris; Michael I Koukourakis; Francesco Pezzella; Stamatia Pouliliou; Kevin C Gatter; Efthimios Sivridis
Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas.
Hematology/oncology and stem cell therapy 2013;6(1):20-5.
2013: Ioannis Abatzoglou; Stamatia Pouliliou; Christos E Zois; Michael I Koukourakis
Establishment and validation of a method for multi-dose irradiation of cells in 96-well microplates.
Biochemical and biophysical research communications 2013;431(3):456-9.
2013: Michael I Koukourakis; Marianthi Panteliadou; Kyriaki Sismanidou; Efthimios Sivridis; Ioannis M Abatzoglou; Alexandra Giatromanolaki
Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection.
International journal of radiation oncology, biology, physics 2013;85(1):e7-13.
2012: Alexandra Giatromanolaki; Michael I Koukourakis; ANASTASIOS KOUTSOPOULOS; Savvas Mendrinos; Efthimios Sivridis
The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.
Cancer biology & therapy 2012;13(13):1284-9.
2012: Marianthi Panteliadou; Panagiotis Pantelis; Kyriaki Sismanidou; Stavros Touloupidis; Pelagia G Tsoutsou; Ioannis Abatzoglou; Evagelia Destouni; Alexandra Giatromanolaki; Michael I Koukourakis
Treatment of invasive bladder cancer with conformal hypofractionated accelerated radiotherapy and amifostine (HypoARC).
Urologic oncology 2012;30(6):813-20.
2012: Michael I Koukourakis; Marianthi Panteliadou; Aikaterini Papadopoulou; Kyriaki Sismanidou; Ioannis Abatzoglou; Stavros Touloupidis
Postoperative pelvic hypofractionated accelerated radiotherapy with cytoprotection (HypoARC) for high-risk or recurrent prostate cancer.
Anticancer research 2012;32(10):4561-8.
2012: Alexandra Giatromanolaki; Adrian L Harris; T Jalava; Michael I Koukourakis; D Laurent; D Lebwohl; G Meinhardt; M M Shi; Efthimios Sivridis; Tanja Trarbach; Gunnar Folprecht; Kevin C Gatter
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.
British journal of cancer 2012;107(7):1044-50.
2012: Michael I Koukourakis
Radiation damage and radioprotectants: new concepts in the era of molecular medicine.
The British journal of radiology 2012;85(1012):313-30.
2012: Michael I Koukourakis; Vassilios Danielidis; Alexandra Giatromanolaki; V Tsakmaki; Efthimios Sivridis
Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.
British journal of cancer 2012;106(5):846-53.
2012: Alexandra Giatromanolaki; Adrian L Harris; Nikolaos E Bechrakis; Michael H Foerster; Kevin C Gatter; Efthimios Sivridis; Georgios St Charitoudis; Gregor Willerding; Michael I Koukourakis
Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
Clinical & experimental metastasis 2012;29(1):11-7.
2011: Marianthi Panteliadou; Kiriaki Pistevou; Stavros Touloupidis; Pelagia G Tsoutsou; Alexandra Giatromanolaki; Christos Kalaitzis; George Kyrgias; Michael I Koukourakis
Concurrent administration of liposomal doxorubicin improves the survival of patients with invasive bladder cancer undergoing hypofractionated accelerated radiotherapy (HypoARC).
Medical oncology (Northwood, London, England) 2011;28(4):1356-62.
2011: Christos E Zois; Alexandra Giatromanolaki; Heikki Kainulainen; Marina Papaiakovou; Efthimios Sivridis; Michael I Koukourakis
"Autophagic flux" in normal mouse tissues: focus on endogenous LC3A processing.
Autophagy 2011;7(11):1371-8.
2011: Alexandra Giatromanolaki; Michael I Koukourakis; ANASTASIOS KOUTSOPOULOS; Vasileios Liberis; Pelagia Chloropoulou; Efthimios Sivridis
High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas.
Gynecologic oncology 2011;123(1):147-51.
2011: Alexandra Giatromanolaki; Aliki Fiska; Efthimios Sivridis; Michael I Koukourakis
The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
Medical oncology (Northwood, London, England) 2011;28(3):745-52.
2011: Michael I Koukourakis; Dirk Laurent; David Lebwohl; Gerold Meinhardt; Michael M Shi; Efthimios Sivridis; Tanja Trarbach; Gunnar Folprecht; Kevin C Gatter; Alexandra Giatromanolaki; Tarja Jalava; Adrian L Harris
Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4892-900.
2011: Georgia Karpathiou; Michael I Koukourakis; Dimitrios Mikroulis; Efthimios Sivridis; Demosthenes Bouros; Marios E Froudarakis; Alexandra Giatromanolaki
Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas.
Chest 2011;140(1):127-34.
2011: Efthimios Sivridis; Michael I Koukourakis; Savvas E Mendrinos; Antonios Karpouzis; Aliki Fiska; Constantinos Kouskoukis; Alexandra Giatromanolaki
Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1.
Melanoma research 2011;21(3):188-95.
2011: Michael I Koukourakis; Dimitra Pitsiava; Alexandra Giatromanolaki; Georgia Kambouromiti; Efthimios Sivridis; Georgios Kartalis
Amifostine-related fever-rash during fractionated radiotherapy: diagnostic and predictive role of C-reactive protein.
American journal of clinical oncology 2011;34(3):281-5.
2011: Michael I Koukourakis; Alexandra Giatromanolaki; Pelagia G Tsoutsou; Nikolaos Lyratzopoulos; Michail Pitiakoudis; George Kouklakis; Pelagia A Chloropoulou; Kostantinos Manolas; Efthimios Sivridis
Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study.
International journal of radiation oncology, biology, physics 2011;80(2):492-8.
2011: Michael I Koukourakis; George Kyrgias; Aikaterini Papadopoulou; Marianthi Panteliadou; Alexandra Giatromanolaki; Efthimios Sivridis; Sophia Mavropoulou; Kriton Kalogeris; Pavlos Nassos; Nicolaos Milioudis; Stavros Touloupidis
Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): an interim analysis of toxicity and efficacy.
Anticancer research 2011;31(5):1745-51.
2011: Efthimios Sivridis; Alexandra Giatromanolaki; Georgia Karpathiou; Antonios Karpouzis; Constantin Kouskoukis; Michael I Koukourakis
LC3A-positive "stone-like" structures in cutaneous squamous cell carcinomas.
The American Journal of dermatopathology 2011;33(3):285-90.
2011: Christos E Zois; Alexandra Giatromanolaki; Efthimios Sivridis; Savvas P Tokmakidis; Sotirios Botaitis; Constantinos Simopoulos; Alexandros Kortsaris; Michael I Koukourakis
Narrow amifostine dose windows define radioprotection outcome, following fractionated whole-body irradiation of mice.
In vivo (Athens, Greece) 2011;25(2):191-6.
2011: Michael I Koukourakis; Vasilios Limberis; Ioannis K Tentes; Emmanuel Kontomanolis; Alexandros Kortsaris; Efthimios Sivridis; Alexandra Giatromanolaki
Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer.
Cytokine 2011;53(3):370-5.
2011: Christos E Zois; Alexandra Giatromanolaki; Heikki Kainulainen; Sotirios Botaitis; Sira Torvinen; Constantinos Simopoulos; Alexandros Kortsaris; Efthimios Sivridis; Michael I Koukourakis
Lung autophagic response following exposure of mice to whole body irradiation, with and without amifostine.
Biochemical and biophysical research communications 2011;404(1):552-8.
2011: Michael I Koukourakis; A Papadopoulou; G Kyrgias
Long-term survival of a patient with multiple abdominal metastasis from endometrial carcinoma treated with multi-portal conformal re-irradiation and chemotherapy.
Hematology/oncology and stem cell therapy 2011;4(1):45-7.
2011: Efthimios Sivridis; Alexandra Giatromanolaki; Vasilios Liberis; Michael I Koukourakis
Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia?
Autophagy 2011;7(1):74-82.
2010: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Michail Pitiakoudis; Kevin C Gatter; Adrian L Harris
Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
British journal of cancer 2010;103(8):1209-14.
2010: Alexandra Giatromanolaki; Michael I Koukourakis; Adrian L Harris; Alexandros Polychronidis; Kevin C Gatter; Efthimios Sivridis
Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas.
Journal of clinical pathology 2010;63(10):867-72.
2010: Michael I Koukourakis; Alexandra Giatromanolaki; Michail Pitiakoudis; George Kouklakis; Pelagia G Tsoutsou; Ioannis Abatzoglou; Marianthi Panteliadou; Kyriaki Sismanidou; Efthimios Sivridis; Teni Boulikas
Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study.
International journal of radiation oncology, biology, physics 2010;78(1):150-5.
2010: Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael I Koukourakis; Alexandra Giatromanolaki
c-erbB-2 and the "triple-state" in early breast carcinomas.
Medical oncology (Northwood, London, England) 2010;27(3):578-84.
2010: Efthimios Sivridis; Alexandra Giatromanolaki; Christos Zois; Michael I Koukourakis
The "stone-like" pattern of autophagy in human epithelial tumors and tumor-like lesions: an approach to the clinical outcome.
Autophagy 2010;6(6):830-3.
2010: Alexandra Giatromanolaki; Maria Bai; Dimitrios Margaritis; Konstantinos L Bourantas; Michael I Koukourakis; Efthimios Sivridis; Kevin C Gatter
Hypoxia and activated VEGF/receptor pathway in multiple myeloma.
Anticancer research 2010;30(7):2831-6.
2010: Efthimios Sivridis; Michael I Koukourakis; Christos E Zois; Ioanna Ledaki; David J P Ferguson; Adrian L Harris; Kevin C Gatter; Alexandra Giatromanolaki
LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.
The American journal of pathology 2010;176(5):2477-89.
2010: Michael I Koukourakis; Pelagia G Tsoutsou; Antonios Karpouzis; Maria Tsiarkatsi; Ilias Karapantzos; Vassilios Daniilidis; Constantinos Kouskoukis
Radiochemotherapy with cetuximab, cisplatin, and amifostine for locally advanced head and neck cancer: a feasibility study.
International journal of radiation oncology, biology, physics 2010;77(1):9-15.
2010: Alexandra Giatromanolaki; G Lyberakidis; Nikolaos Lyratzopoulos; Michael I Koukourakis; Efthimios Sivridis; Costantinos Manolas
Angiogenesis and angiogenic factor expression in thyroid cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2010;15(2):357-61.
2010: Savvas G Eleftheriadis; Efthimios Sivridis; ANASTASIOS KOUTSOPOULOS; Zisis G Galatoudis; Pelagia A Chloropoulou; Michael I Koukourakis; Vassilios Didilis; Georgios Bougioukas; Alexandra Giatromanolaki
One-lung ventilation and HIF1alpha expression in lung cancer and pneumothorax.
Anticancer research 2010;30(4):1143-8.
2010: Pelagia G Tsoutsou; Yazid Belkacemi; Joseph GLIGOROV; Abraham Kuten; Hamouda Boussen; Nuran Bese; Michael I Koukourakis
Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider.
The oncologist 2010;15(11):1169-78.
2009: Michael I Koukourakis; Alexandra Giatromanolaki; Helen Sheldon; Francesca M Buffa; George Kouklakis; Jiannis Ragoussis; Efthimios Sivridis; Adrian L Harris
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7069-76.
2009: Theodore Lialiaris; E Kotsiou; S Pouliliou; D Kareli; H Makrinou; A Kouskoukis; Fotini Papachristou; Michael I Koukourakis
Cytoprotective activity of amifostine on cultured human lymphocytes exposed to irinotecan.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2009;47(10):2445-9.
2009: Alexandra Giatromanolaki; Aliki Fiska; Dimitra Pitsiava; George Kartalis; Michael I Koukourakis; Efthimios Sivridis
Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression.
In vivo (Athens, Greece) 2009;23(5):699-703.
2009: Pelagia G Tsoutsou; Michael I Koukourakis; David Azria; Yazid Belkacémi
Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives.
Critical reviews in oncology/hematology 2009;71(2):102-16.
2009: Michael I Koukourakis; Pelagia G Tsoutsou; Ioannis M Abatzoglou; Kyriaki Sismanidou; Alexandra Giatromanolaki; Efthimios Sivridis
Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
International journal of radiation oncology, biology, physics 2009;74(4):1173-80.
2009: Michael I Koukourakis; Pelagia G Tsoutsou; Ioannis Abatzoglou; Georgia Soulimioti; Kyriaki Sismanidou; Vassilios Liberis; Alexandra Giatromanolaki; Efthimios Sivridis; George Galazios
Postoperative accelerated radiotherapy with cytoprotection followed by three-dimensional conformal boost in patients with early endometrial/cervical cancer.
Tumori 2009;95(4):455-60.
2009: Michael I Koukourakis; Georgia Kambouromiti; Dimitra Pitsiava; Pelagia Tsousou; Maria Tsiarkatsi; George Kartalis
Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication.
Inflammation 2009;32(3):169-75.
2009: Michael I Koukourakis; Pelagia G Tsoutsou; Ioannis Abatzoglou
Computed tomography assessment of lung density in patients with lung cancer treated with accelerated hypofractionated radio-chemotherapy supported with amifostine.
American journal of clinical oncology 2009;32(3):258-61.
2009: Christos E Zois; Michael I Koukourakis
Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies?
Autophagy 2009;5(4):442-50.
2009: Ioannis Abatzoglou; Photios Anninos; I Tsalafoutas; Michael I Koukourakis
Multi-channel magnetoencephalogram on Alzheimer disease patients.
Journal of integrative neuroscience 2009;8(1):13-22.
2009: Michael I Koukourakis; Alexandra Giatromanolaki; Stuart Winter; Russel Leek; Efthimios Sivridis; Adrian L Harris
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.
Oncology 2009;77(5):285-92.
2009: George V Koukourakis; Constantinos N Baksevanis; Haralambos Zambatis; Angelos Gritzapis; Efstratios Maltezos; Costantinos Simopoulos; Michael I Koukourakis
Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
International journal of radiation biology 2009;85(1):96-104.
2009: Michael I Koukourakis; Emmanuel Kontomanolis; Alexandra Giatromanolaki; Efthimios Sivridis; Vasilios Liberis
Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Gynecologic and obstetric investigation 2009;67(3):162-8.
2008: Alexandra Giatromanolaki; Michael I Koukourakis; Francesco Pezzella; Efthimios Sivridis; Helen Turley; Adrian L Harris; Kevin C Gatter
Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
Hematological oncology 2008;26(4):219-24.
2008: Alexandros Polychronidis; Alexandra K Tsaroucha; Sebachedin Perente; Alexandra Giatromanolaki; Michael I Koukourakis; Constantinos Simopoulos
Port-site metastasis of extrahepatic bile duct carcinoma after laparoscopic cholecystectomy without evidence of a primary tumour.
Acta chirurgica Belgica 2008;108(6):768-70.
2008: Alexandra Giatromanolaki; Michael I Koukourakis; Francesco Pezzella; Efthimios Sivridis; Helen Turley; Adrian L Harris; Kevin C Gatter
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
Leukemia & lymphoma 2008;49(11):2181-6.
2008: Michael I Koukourakis; Constantinos Simopoulos; Michael Pitiakoudis; Nikolaos Lyratzopoulos; Konstantinos Romanidis; Alexandra Giatromanolaki; Alexandros Polychronidis; George Kouklakis; Efthimios Sivridis; George Minopoulos; Konstantinos Manolas
Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study.
Anticancer research 2008;28(5B):3035-40.
2008: Alexandra Giatromanolaki; Gaynor J Bates; Michael I Koukourakis; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris; Alison H Banham
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
Gynecologic oncology 2008;110(2):216-21.
2008: Alexandra Giatromanolaki; Michael I Koukourakis; Francesco Pezzella; Helen Turley; Efthimios Sivridis; Demosthenes Bouros; Georgios Bougioukas; Adrian L Harris; Kevin C Gatter
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
Cancer letters 2008;262(1):87-93.
2008: Pelagia G Tsoutsou; Marios E Froudarakis; Demosthenes Bouros; Michael I Koukourakis
Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC).
Anticancer research 2008;28(2B):1349-54.
2008: Alexandra Giatromanolaki; Michael I Koukourakis; Kevin C Gatter; Adrian L Harris; Efthimios Sivridis
BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
Journal of clinical pathology 2008;61(2):217-20.
2008: Ioannis Abatzoglou; Pelagia Tsoutsou; Michael I Koukourakis
A plesiotherapy technique for the post-operative treatment of skin cancer using Ir192 microSelectron.
Journal of applied clinical medical physics / American College of Medical Physics 2008;9(4):2890.
2008: Michael I Koukourakis; Alexandra Giatromanolaki; Vassilios Danielidis; Efthimios Sivridis
Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
International journal of radiation biology 2008;84(1):47-52.
2007: Michael I Koukourakis; George Patlakas; Marios E Froudarakis; George Kyrgias; John Skarlatos; Ioannis Abatzoglou; Georgios Bougioukas; Demosthenes Bouros
Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.
Anticancer research 2007;27(5B):3625-31.
2007: Michael I Koukourakis; Alexandra Giatromanolaki; Georgios Bougioukas; Efthimios Sivridis
Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma.
Cancer biology & therapy 2007;6(9):1476-9.
2007: I Abatzoglou; Photios Anninos; Adam Adamopoulos; Michael I Koukourakis
Nonlinear analysis of brain magnetoencephalographic activity in Alzheimer disease patients.
Acta neurologica Belgica 2007;107(2):34-9.
2007: Luigi Corti; Lamberto Toniolo; Caterina Boso; Flavio Colaut; Davide Fiore; Pier Carlo Muzzio; Michael I Koukourakis; Renzo Mazzarotto; Michele Pignataro; Lucio Loreggian; Guido Sotti
Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Lasers in surgery and medicine 2007;39(5):394-402.
2007: Michael I Koukourakis; Ioannis Mavanis; George Kouklakis; Michail Pitiakoudis; George Minopoulos; Costantinos Manolas; Constantinos Simopoulos
Early antivascular effects of bevacizumab anti-VEGF monoclonal antibody on colorectal carcinomas assessed with functional CT imaging.
American journal of clinical oncology 2007;30(3):315-8.
2007: Michael I Koukourakis; Christos Tsolos; Stavros Touloupidis
Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Urology 2007;69(2):245-50.
2007: Alexandra Giatromanolaki; Michael I Koukourakis; Constantinos Simopoulos; Efthimios Sivridis
Metastatic cancer cells from c-erbB-2 negative primary breast cancer maintain the original c-erbB-2/HIF1alpha phenotype.
Cancer biology & therapy 2007;6(2):153-5.
2007: Alexandra Giatromanolaki; Stamatia Kotsiou; Michael I Koukourakis; Efthimios Sivridis
Angiogenic factor expression in hepatic cirrhosis.
Mediators of inflammation 2007;2007():67187.
2007: Michael I Koukourakis; Ioannis Abatzoglou; Stavros Touloupidis; Ioannis Manavis
Biological dose volume histograms during conformal hypofractionated accelerated radiotherapy for prostate cancer.
Medical physics 2007;34(1):76-80.
2006: Pelagia G Tsoutsou; Michael I Koukourakis
Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research.
International journal of radiation oncology, biology, physics 2006;66(5):1281-93.
2006: Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Helen Turley; Adrian L Harris; Michael I Koukourakis
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
Gynecologic oncology 2006;103(3):912-8.
2006: John Manavis; John Ambatzoglou; Kyriaki Sismanidou; Michael I Koukourakis
Computed tomography (CT) scan evaluation of late toxicity following hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) in breast cancer patients treated with conservative surgery.
American journal of clinical oncology 2006;29(5):479-83.
2006: Michael I Koukourakis; Michail Pitiakoudis; Alexandra Giatromanolaki; Alexandra Tsarouha; Alexandros Polychronidis; Efthimios Sivridis; Constantinos Simopoulos
Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis.
Cancer science 2006;97(10):1056-60.
2006: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris
Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4301-8.
2006: Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Simopoulos; Alexandros Polychronidis; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
Journal of surgical oncology 2006;94(3):242-7.
2006: Michael I Koukourakis; Dimitrios Papazoglou; Alexandra Giatromanolaki; Ioannis Panagopoulos; Efstratios Maltezos; Adrian L Harris; Kevin C Gatter; Efthimios Sivridis
C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(3):257-62.
2006: Alexandra Giatromanolaki; Efthimios Sivridis; Michael I Koukourakis
Angiogenesis in colorectal cancer: prognostic and therapeutic implications.
American journal of clinical oncology 2006;29(4):408-17.
2006: Michael I Koukourakis; Alexandra Giatromanolaki; Alexandros Polychronidis; Constantinos Simopoulos; Kevin C Gatter; Adrian L Harris; Efthimios Sivridis
Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
Cancer science 2006;97(7):582-8.
2006: Efthimios Sivridis; Alexandra Giatromanolaki; Georgios Galazios; Michael I Koukourakis
Node-related factors and survival in node-positive breast carcinomas.
Breast (Edinburgh, Scotland) 2006;15(3):382-9.
2006: Michael I Koukourakis; Ioannis Abatzoglou; Leonidas Sivridis; Maria Tsarkatsi; Helen Delidou
Individualization of the subcutaneous amifostine dose during hypofractionated / accelerated radiotherapy.
Anticancer research 2006;26(3B):2437-43.
2006: Alexandra Giatromanolaki; Michael I Koukourakis; Helen Turley; Efthimios Sivridis; Adrian L Harris; Kevin C Gatter
Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(5):701-7.
2006: Alexandra Giatromanolaki; Efthimios Sivridis; Aliki Fiska; Michael I Koukourakis
Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2006;14(1):78-82.
2006: Michael I Koukourakis; Søren M Bentzen; Alexandra Giatromanolaki; George D Wilson; Frances M Daley; Michele I Saunders; Stanley Dische; Efthimios Sivridis; Adrian L Harris
Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):727-35.
2006: Michael I Koukourakis; Efstratios Maltezos
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
Anti-cancer drugs 2006;17(2):133-8.
2006: Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
Cancer research 2006;66(2):632-7.
2006: Michael I Koukourakis; Stavros Touloupidis
External beam radiotherapy for prostate cancer: current position and trends.
Anticancer research 2006;26(1B):485-94.
2006: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris; Alison H Banham
Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(1):9-16.
2005: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris
Inclusion of vasculature-related variables in the Dukes staging system of colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8653-60.
2005: Michael I Koukourakis; Vassilios Danielidis
Preventing radiation induced xerostomia.
Cancer treatment reviews 2005;31(7):546-54.
2005: Michael I Koukourakis; John Manavis; Constantinos Simopoulos; Vasilis Liberis; Alexandra Giatromanolaki; Efthimios Sivridis
Hypofractionated accelerated radiotherapy with cytoprotection combined with trastuzumab, liposomal doxorubicine, and docetaxel in c-erbB-2-positive breast cancer.
American journal of clinical oncology 2005;28(5):495-500.
2005: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis
Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress.
Journal of clinical pathology 2005;58(10):1033-8.
2005: George Patlakas; Demosthenes Bouros; Sofia Tsantekidou-Pozova; Michael I Koukourakis
Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer.
Anticancer research 2005;25(2B):1427-31.
2005: John Manavis; Leonidas Sivridis; Michael I Koukourakis
Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease.
Clinical imaging 2005;29(2):128-33.
2005: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Simopoulos; Kevin C Gatter; Adrian L Harris; D G Jackson
LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
Journal of clinical pathology 2005;58(2):202-6.
2005: Michael I Koukourakis; Alexandra Giatromanolaki; Constantinos Simopoulos; Alexandros Polychronidis; Efthimios Sivridis
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
Clinical & experimental metastasis 2005;22(1):25-30.
2005: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris
Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.
Neoplasia (New York, N.Y.) 2005;7(1):1-6.
2004: Alexandra Giatromanolaki; Michael I Koukourakis; Constantinos Simopoulos; Alexandros Polychronidis; Kevin C Gatter; Adrian L Harris; Efthimios Sivridis
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7972-7.
2004: Michael I Koukourakis; Dimitrios Papazoglou; Alexandra Giatromanolaki; Georgios Bougioukas; Efstratios Maltezos; Efthimios Sivridis; Efthimios Siviridis
VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46(3):293-8.
2004: Alexandra Giatromanolaki; Efthimios Sivridis; Panagiotis Tsikouras; I Manavis; Georgios B Maroulis; Michael I Koukourakis
Angiogenesis and vascular survival ability in ovarian adenocarcinomas.
Virchows Archiv : an international journal of pathology 2004;445(5):521-6.
2004: Michael I Koukourakis; Stavros Touloupidis; John Manavis; Ioannis Abatzoglou; Kiriaki Sismanidou; Leonidas Sivridis
Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience.
Anticancer research 2004;24(5B):3239-43.
2004: Alexandra Giatromanolaki; Michael I Koukourakis; Heidi M Sowter; Efthimios Sivridis; Spencer Gibson; Kevin C Gatter; Adrian L Harris
BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5566-71.
2004: Alexandra Giatromanolaki; Efthimios Sivridis; Michael I Koukourakis
Tumour angiogenesis: vascular growth and survival.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(7-8):431-40.
2004: Alexandra Giatromanolaki; Michael I Koukourakis; Konstantinos Ritis; Konstantinos Mimidis; Efthimios Sivridis
Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression.
Cytokine 2004;26(4):164-8.
2004: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Jaromir Pastorek; Ilias Karapantzos; Kevin C Gatter; Adrian L Harris
Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
International journal of radiation oncology, biology, physics 2004;59(1):67-71.
2004: Dimitrios Papazoglou; Georgios Galazios; Michael I Koukourakis; Emmanuel N Kontomanolis; Efstratios Maltezos
Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery.
Acta obstetricia et gynecologica Scandinavica 2004;83(5):461-5.
2004: Dimitrios Papazoglou; Georgios Galazios; Michael I Koukourakis; Ioannis Panagopoulos; Emmanuel N Kontomanolis; Konstantinos Papatheodorou; Efstratios Maltezos
Vascular endothelial growth factor gene polymorphisms and pre-eclampsia.
Molecular human reproduction 2004;10(5):321-4.
2004: Alexandra Giatromanolaki; Michael I Koukourakis; Stylianos Kakolyris; Dimitris Mavroudis; Charalambos Kouroussis; Chrysa Mavroudi; Maria Perraki; Efthimios Sivridis; Vassilis Georgoulias
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
International journal of cancer. Journal international du cancer 2004;108(4):620-7.
2004: Panagiotis E Antoniou; Photios Anninos; Haritomeni Piperidou; Adam Adamopoulos; Athanasia Kotini; Michael I Koukourakis; Efthimios Sivridis
Non linear analysis of magnetoencephalographic signals as a tool for assessing malignant lesions of the brain: first results.
Brain topography 2004;17(2):117-23.
2004: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis
"Stromatogenesis" and tumor progression.
International journal of surgical pathology 2004;12(1):1-9.
2004: Michael I Koukourakis; Alexandra Giatromanolaki; Wen Chong; Constantinos Simopoulos; Alexandros Polychronidis; Efthimios Sivridis; Adrian L Harris
Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha.
Cancer chemotherapy and pharmacology 2004;53(1):8-14.
2003: Michael I Koukourakis
Amifostine: is there evidence of tumor protection?
Seminars in oncology 2003;30(6 Suppl 18):18-30.
2003: Alexandra Giatromanolaki; Michael I Koukourakis; Constantinos Simopoulos; Alexandros Polychronidis; Efthimios Sivridis
Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(10):879-83.
2003: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis
The vascular network of tumours--what is it not for?
The Journal of pathology 2003;201(2):173-80.
2003: Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Kouskoukis; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
Melanoma research 2003;13(5):493-501.
2003: Michael I Koukourakis; Alexandra Giatromanolaki; Rolf Brekken; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris; E Helene Sage
Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
Cancer research 2003;63(17):5376-80.
2003: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Georgios Bougioukas; Vassilios Didilis; Kevin C Gatter; Adrian L Harris
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
British journal of cancer 2003;89(5):877-85.
2003: Andreas N Kapsoritakis; Aekaterini Sfiridaki; Efstratios Maltezos; Kostantinos Simopoulos; Alexandra Giatromanolaki; Efthimios Sivridis; Michael I Koukourakis
Vascular endothelial growth factor in inflammatory bowel disease.
International journal of colorectal disease 2003;18(5):418-22.
2003: Michael I Koukourakis; Constantinos Simopoulos; George Minopoulos; George Patlakas; Alexandros Polychronidis; Vassilis Limberis; Kostantinos Romanides; Michael Pitiacoudis; Costantinos Manolas
Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous route.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3288-93.
2003: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis
Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(4):199-202.
2003: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; Helen Turley; Charles C Wykoff; Kevin C Gatter; Adrian L Harris
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
The Journal of pathology 2003;200(2):222-8.
2003: Michael I Koukourakis; Alexandra Giatromanolaki; G Galazios; Efthimios Sivridis
Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
British journal of cancer 2003;88(5):711-7.
2003: Michael I Koukourakis; Constantinos Simopoulos; Alexandros Polychronidis; Sebachedin Perente; Sotirios Botaitis; Alexandra Giatromanolaki; Efthimios Sivridis
The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF pre-treatment status?
Anticancer research 2003;23(2C):1673-80.
2003: Alexandra Giatromanolaki; Efthimios Sivridis; Efstratios Maltezos; Dimitrios Papazoglou; Constantinos Simopoulos; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Journal of clinical pathology 2003;56(3):209-13.
2003: Michael I Koukourakis; Sophia Ktenidou-Kartali; George Bourikas; Georgios Kartalis; Costas Tsatalas
Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patients.
Cancer immunology, immunotherapy : CII 2003;52(2):127-31.
2003: Alexandra Giatromanolaki; Efthimios Sivridis; Efstratios Maltezos; Nick Athanassou; Dimitrios Papazoglou; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.
Arthritis research & therapy 2003;5(4):R193-201.
2003: Michael I Koukourakis; Costantinos Manolas; George Minopoulos; Alexandra Giatromanolaki; Efthimios Sivridis
Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and early relapse in node-negative ductal carcinoma of the breast.
International journal of surgical pathology 2003;11(1):29-34.
2003: Kenneth J O'Byrne; Jonathan Goddard; Alexandra Giatromanolaki; Michael I Koukourakis
Vascular endothelial growth factor expression in non-small cell lung cancer.
Methods in molecular medicine 2003;74():357-73.
2002: Michael I Koukourakis
Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.
Seminars in oncology 2002;29(6 Suppl 19):42-6.
2002: Alexandra Giatromanolaki; Efthimios Sivridis; Efstratios Maltezos; Michael I Koukourakis
Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.
Seminars in oncology 2002;29(6 Suppl 19):14-21.
2002: Michael I Koukourakis; Alexandra Giatromanolaki; V Liberis; Efthimios Sivridis
Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer.
Anticancer research 2002;22(6C):4137-40.
2002: Efthimios Sivridis; Alexandra Giatromanolaki; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Cancer 2002;95(5):1055-63.
2002: Michael I Koukourakis; K Romanidis; Marios E Froudarakis; G Kyrgias; G V Koukourakis; George Retalis; N Bahlitzanakis
Concurrent administration of Docetaxel and Stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection.
British journal of cancer 2002;87(4):385-92.
2002: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Simopoulos; Helen Turley; Kate L Talks; Kevin C Gatter; Adrian L Harris
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
International journal of radiation oncology, biology, physics 2002;53(5):1192-202.
2002: Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Simopoulos; Alexandros Polychronidis; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Thymidine phosphorylase expression in gallbladder adenocarcinomas.
International journal of surgical pathology 2002;10(3):181-8.
2002: Michael I Koukourakis; Andreas N Kapsoritakis; Efstratios Maltezos; Spiridon Potamiano; Iannis Mouzas; Helias Kouroumalis
Unexpected toxicity after low-dose docetaxel treatment of a cancer patient with clinically latent HCV-positive hepatic cirrhosis.
Anticancer research 2002;22(4):2491-2.
2002: Efthimios Sivridis; Alexandra Giatromanolaki; I Papadopoulos; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.
British journal of cancer 2002;86(9):1465-71.
2002: Alexandra Giatromanolaki; Efthimios Sivridis; George Minopoulos; Alexandros Polychronidis; Costantinos Manolas; Constantinos Simopoulos; Michael I Koukourakis
Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1185-91.
2002: Efthimios Sivridis; Alexandra Giatromanolaki; Panagiotis Anastasiadis; Loukas Georgiou; Kevin C Gatter; Adrian L Harris; Roy Bicknell; Michael I Koukourakis
Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
The Journal of pathology 2002;196(4):416-22.
2002: Michael I Koukourakis
Amifostine in clinical oncology: current use and future applications.
Anti-cancer drugs 2002;13(3):181-209.
2002: Andreas N Kapsoritakis; Spiros P Potamianos; Michael I Koukourakis; Maria Tzardi; Iannis Mouzas; Maria Roussomoustakaki; Georgios Alexandrakis; Elias A Kouroumalis
Diminutive polyps of large bowel should be an early target for endoscopic treatment.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002;34(2):137-40.
2002: Alexandra Giatromanolaki; Efthimios Sivridis; Michael I Koukourakis; Alexandros Polychronidis; Constantinos Simopoulos
Prognostic role of angiogenesis in operable carcinoma of the gallbladder.
American journal of clinical oncology 2002;25(1):38-41.
2002: Alexandra Giatromanolaki; Efthimios Sivridis; Constantinos Simopoulos; Alexandros Polychronidis; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer.
Clinical & experimental metastasis 2002;19(8):673-9.
2002: Stylianos Kakolyris; Charalambos Kouroussis; Michael I Koukourakis; Dimitris Mavroudis; D Marvroudis; Konstantinos Malas; Nikolaos Vardakis; Vassiliki Bozionelou; Kostas Kalbakis; Vassilis Georgoulias
A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
Oncology 2002;63(3):213-8.
2002: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis; L Georgiou; Panagiotis Anastasiadis
Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
Histopathology 2002;40(1):92-100.
2002: Michael I Koukourakis; Alexandra Giatromanolaki; Charalambos Kouroussis; Stylianos Kakolyris; Efthimios Sivridis; Chryssi Frangiadaki; George Retalis; Vassilis Georgoulias
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
International journal of radiation oncology, biology, physics 2002;52(1):144-55.
2001: Alexandra Giatromanolaki; Efthimios Sivridis; Rolf Brekken; PE Thorpe; P Anastasiadis; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
Cancer 2001;92(10):2569-77.
2001: Stylianos Kakolyris; Alexandra Giatromanolaki; Michael I Koukourakis; LG Kaklamanis; Charalambos Kouroussis; Vassiliki Bozionelou; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39.
Anticancer research 2001;21(6B):4311-6.
2001: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; K Simopoulos; G Pissakas; Kevin C Gatter; Adrian L Harris
Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy.
Anticancer research 2001;21(6B):4301-9.
2001: Michael I Koukourakis
Tumour angiogenesis and response to radiotherapy.
Anticancer research 2001;21(6B):4285-300.
2001: Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; K Simopoulos; Jaromir Pastorek; Charles C Wykoff; Kevin C Gatter; Adrian L Harris
Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3399-403.
2001: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; Jaromir Pastorek; Charles C Wykoff; Kevin C Gatter; Adrian L Harris
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Cancer research 2001;61(21):7992-8.
2001: Sophia Koukouraki; Michael I Koukourakis; E Vagios; Antigoni Velidaki; Dimitris D Tsiftsis; Nikolaos Karkavitsas
The role of 99m Tc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions.
Nuclear medicine communications 2001;22(11):1243-8.
2001: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; Helen Turley; Kate L Talks; Francesco Pezzella; Kevin C Gatter; Adrian L Harris
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
British journal of cancer 2001;85(6):881-90.
2001: Michael I Koukourakis; D Yannakakis
High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
Anticancer research 2001;21(4B):2973-8.
2001: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis; P Anastasiadis
Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.
Virchows Archiv : an international journal of pathology 2001;438(5):470-7.
2001: Alexandra Giatromanolaki; Efthimios Sivridis; N Athanassou; E Zois; PE Thorpe; Rolf Brekken; Kevin C Gatter; Adrian L Harris; I M Koukourakis; Michael I Koukourakis
The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
The Journal of pathology 2001;194(1):101-8.
2001: Michael I Koukourakis; Alexandra Giatromanolaki; Stylianos Kakolyris; E Sivridis; Vassilis Georgoulias; G Funtzilas; I D Hickson; Kevin C Gatter; Adrian L Harris
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.
International journal of radiation oncology, biology, physics 2001;50(1):27-36.
2001: Michael I Koukourakis; Alexandra Giatromanolaki; J Skarlatos; Luigi Corti; Stella Blandamura; M Piazza; K C Gatter; A L Harris
Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.
Cancer research 2001;61(5):1830-2.
2001: Andreas N Kapsoritakis; Michael I Koukourakis; Aekaterini Sfiridaki; Spiros P Potamianos; M G Kosmadaki; Ioannis E Koutroubakis; Elias A Kouroumalis
Mean platelet volume: a useful marker of inflammatory bowel disease activity.
The American journal of gastroenterology 2001;96(3):776-81.
2001: Stylianos Kakolyris; John Souglakos; Charalambos Kouroussis; Nikolaos Androulakis; Dimitris Mavroudis; Kostas Kalbakis; Athanasios Kotsakis; Nikolaos Vardakis; Michael I Koukourakis; J Romanos; Vassilis Georgoulias
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
Oncology 2001;60(3):207-13.
2001: Michael I Koukourakis; Luigi Corti; J Skarlatos; Alexandra Giatromanolaki; Barbara Krammer; Stella Blandamura; M Piazza; Thomas Verwanger; G Schnitzhofer; J Kostandelos; K Beroukas
Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy.
Anticancer research 2001;21(1B):663-8.
2000: Andreas N Kapsoritakis; Spiros P Potamianos; Aekaterini Sfiridaki; Michael I Koukourakis; Ioannis E Koutroubakis; Maria Roussomoustakaki; Orestes N Manousos; Elias A Kouroumalis
Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
The American journal of gastroenterology 2000;95(12):3478-81.
2000: Michael I Koukourakis; Sophia Koukouraki; Ioannis Fezoulidis; Nikolaos Kelekis; G Kyrias; Spiros Archimandritis; Nikolaos Karkavitsas
High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.
British journal of cancer 2000;83(10):1281-6.
2000: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; K O'Byrne; Kevin C Gatter; Adrian L Harris
'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
The Journal of pathology 2000;192(2):140-9.
2000: Athanasios Kotsakis; Evanthia Sarra; M Peraki; Michael I Koukourakis; Stella Apostolaki; John Souglakos; E Mavromanomakis; John Vlachonikolis; Vassilis Georgoulias
Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis.
Cancer 2000;89(6):1380-6.
2000: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis; Roy Bicknell; Adrian L Harris; Kevin C Gatter
Thymidine phosphorylase expression in normal and hyperplastic endometrium.
Journal of clinical pathology 2000;53(9):704-8.
2000: Sophia Koukouraki; P Prassopoulos; Michael I Koukourakis; Antigoni Velidaki; Nikolaos Karkavitsas
Tc-99m sestamibi scintigraphy: an effective method to predict the response of thymoma after radiotherapy.
Clinical nuclear medicine 2000;25(9):727-8.
2000: Michael I Koukourakis; Alexandra Giatromanolaki; P E Thorpe; Rolf Brekken; E Sivridis; Stylianos Kakolyris; V Georgoulias; Kevin C Gatter; Adrian L Harris
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Cancer research 2000;60(11):3088-95.
2000: Michael I Koukourakis; G Kyrias; Stylianos Kakolyris; Charalambos Kouroussis; C Frangiadaki; Alexandra Giatromanolaki; George Retalis; Vassilis Georgoulias
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2226-33.
2000: Michael I Koukourakis; Alexandra Giatromanolaki; Stylianos Kakolyris; Marios E Froudarakis; Vassilis Georgoulias; George Retalis; N Bahlitzanakis
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.
Medical oncology (Northwood, London, England) 2000;17(2):135-43.
2000: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; K O'Byrne; G Cox; PE Thorpe; Kevin C Gatter; Adrian L Harris
Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1917-21.
2000: Luigi Corti; J Skarlatos; Caterina Boso; Fabrizio Cardin; L Kosma; Michael I Koukourakis; Alexandra Giatromanolaki; Lorenzo Norberto; M Shaffer; K Beroukas
Outcome of patients receiving photodynamic therapy for early esophageal cancer.
International journal of radiation oncology, biology, physics 2000;47(2):419-24.
2000: K J O'Byrne; Michael I Koukourakis; Alexandra Giatromanolaki; G Cox; Helen Turley; William P Steward; Kevin Gatter; A L Harris
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
British journal of cancer 2000;82(8):1427-32.
2000: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; G Fountzilas
c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Anticancer research 2000;20(2A):997-1004.
2000: Michael I Koukourakis; Alexandra Giatromanolaki; G Fountzilas; E Sivridis; K C Gatter; A L Harris
Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):381-9.
2000: Alexandra Giatromanolaki; Michael I Koukourakis; Efthimios Sivridis; PE Thorpe; Rolf Brekken; S Konstantinos; G Fountzilas; Kevin C Gatter; Adrian L Harris
Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.
Clinical & experimental metastasis 2000;18(4):313-9.
2000: Michael I Koukourakis
Microvessel density, thymidine phosphorylase expression and resistance of head and neck cancer to chemo-radiotherapy.
Advances in experimental medicine and biology 2000;476():285-9.
2000: LG Kaklamanis; Stylianos Kakolyris; Michael I Koukourakis; Kevin C Gatter; Adrian L Harris
From hyperplasia to neoplasia and invasion: angiogenesis in the colorectal adenoma-carcinoma model.
Advances in experimental medicine and biology 2000;476():249-66.
2000: Michael I Koukourakis; Sophia Koukouraki; Alexandra Giatromanolaki; S Kakolyris; V Georgoulias; Antigoni Velidaki; Spiros Archimandritis; N N Karkavitsas
High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy.
Acta oncologica (Stockholm, Sweden) 2000;39(2):207-11.
2000: Michael I Koukourakis; Alexandra Giatromanolaki; F Guddo; LG Kaklamanis; M Vignola; Stylianos Kakolyris; H Turley; V Georgoulias; Giovanni Bonsignore; Kevin C Gatter; Adrian L Harris
c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(1):104-14.
2000: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis; N Agnantis
Lectin-binding patterns in normal, hyperplastic and neoplastic endometrium: the prognostic value of concanavalin A.
Virchows Archiv : an international journal of pathology 2000;436(1):52-8.
1999: Michael I Koukourakis; C S Flordellis; Alexandra Giatromanolaki; Sophia Koukouraki; Andreas N Kapsoritakis; Spiros P Potamianos; G Retalis; Efthimios Sivridis; B Salsaa; A L Harris; M I Maragoudakis
Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):3970-6.
1999: Stylianos Kakolyris; Charalabos Kourousis; Michael I Koukourakis; Nikolaos Androulakis; Lambros Vamvakas; Sofia Agelaki; Dora Hatzidaki; George Samonis; Dimitris D Tsiftsis; Vassilis Georgoulias
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Stylianos Kakolyris; Alexandra Giatromanolaki; Michael I Koukourakis; I M Leigh; V Georgoulias; P Kanavaros; Efthimios Sivridis; K C Gatter; Adrian L Harris
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
Cancer research 1999;59(21):5602-7.
1999: Michael I Koukourakis; Sophia Koukouraki; Alexandra Giatromanolaki; Spiros Archimandritis; J Skarlatos; K Beroukas; John G Bizakis; G Retalis; N Karkavitsas; E S Helidonis
Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3512-21.
1999: Stylianos Kakolyris; Alexandra Giatromanolaki; Michael I Koukourakis; LG Kaklamanis; P Kanavaros; Ian D Hickson; G Barzilay; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC).
The Journal of pathology 1999;189(3):351-7.
1999: Alexandra Giatromanolaki; George P Stathopoulos; E Tsiompanou; E Tsiobanou; C Papadimitriou; Vassilis Georgoulias; K C Gatter; A L Harris; Michael I Koukourakis
Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Cancer 1999;86(8):1421-30.
1999: Michael I Koukourakis; N Bahlitzanakis; Marios E Froudarakis; Alexandra Giatromanolaki; Vassilis Georgoulias; S Koumiotaki; M Christodoulou; G Kyrias; J Skarlatos; J Kostantelos; K Beroukas
Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
British journal of cancer 1999;80(11):1792-6.
1999: Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis; Roy Bicknell; Adrian L Harris; Kevin C Gatter
Thymidine phosphorylase expression in endometrial carcinomas.
Clinical & experimental metastasis 1999;17(5):445-50.
1999: Stylianos Kakolyris; George Samonis; Michael I Koukourakis; J Vlachonicolis; Kostas Kalbakis; Sofia Agelaki; george chalkiadakis; Elias Sanidas; Dimitris D Tsiftsis; Vassilis Georgoulias
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
American journal of clinical oncology 1999;22(3):273-7.
1999: Michael I Koukourakis; John G Bizakis; Charalambos E Skoulakis; Dionysios E Kyrmizakis; Alexandra Giatromanolaki; C E Papadakis; Emmanuel P Prokopakis; Zaharias E Amanakis; E S Hellidonis
Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study.
Anticancer research 1999;19(3B):2305-9.
1999: Alexandra Giatromanolaki; Michael I Koukourakis; V Georgoulias; K C Gatter; A L Harris; G Fountzilas
Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer.
International journal of cancer. Journal international du cancer 1999;80(6):810-7.
1999: Michael I Koukourakis; Alexandra Giatromanolaki; KJ O'Byrne; J Cox; Barbara Krammer; Kevin C Gatter; Adrian L Harris
bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Clinical & experimental metastasis 1999;17(7):545-54.
1999: Michael I Koukourakis; Alexandra Giatromanolaki; S Schiza; Stylianos Kakolyris; Vassilis Georgoulias
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
International journal of radiation oncology, biology, physics 1999;43(1):107-14.
1998: Stylianos Kakolyris; LG Kaklamanis; Alexandra Giatromanolaki; Michael I Koukourakis; Ian D Hickson; G Barzilay; Helen Turley; Russell Leek; P Kanavaros; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease.
Histopathology 1998;33(6):561-9.
1998: Alexandra Giatromanolaki; Michael I Koukourakis; S Kakolyris; Helen Turley; K O'Byrne; P A Scott; F Pezzella; Vassilis Georgoulias; Adrian L Harris; Kevin C Gatter
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3017-24.
1998: Michael I Koukourakis; I Stefanaki; Alexandra Giatromanolaki; C Frangiadaki; A Armenaki; Vassilis Georgoulias; E Koumandakis; A Kranidis; E Helidonis
Fractionated carboplatin radiosensitization: a phase I dose-escalation study.
American journal of clinical oncology 1998;21(6):595-601.
1998: Alexandra Giatromanolaki; G Fountzilas; Michael I Koukourakis; P Arapandoni; V Theologi; Stylianos Kakolyris; V Georgoulias; A L Harris; K C Gatter
Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.
Clinical & experimental metastasis 1998;16(7):665-72.
1998: Stylianos Kakolyris; George Samonis; Michael I Koukourakis; I Vlachonicolis; george chalkiadakis; Kostas Kalbakis; I Souglakos; Sofia Agelaki; P Toloudis; Vassilis Georgoulias
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
American journal of clinical oncology 1998;21(5):505-8.
1998: F Guddo; Alexandra Giatromanolaki; Michael I Koukourakis; C Reina; Antonio M Vignola; G Chlouverakis; J Hilkens; Kevin C Gatter; Adrian L Harris; Giovanni Bonsignore
MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
Journal of clinical pathology 1998;51(9):667-71.
1998: Alexandra Giatromanolaki; Efthimios Sivridis; Michael I Koukourakis; Adrian L Harris; Kevin C Gatter
Bcl-2 and p53 expression in stage I endometrial carcinoma.
Anticancer research 1998;18(5B):3689-93.
1998: Michael I Koukourakis; Charalabos Kourousis; M Kamilaki; S Koukouraki; Alexandra Giatromanolaki; Stylianos Kakolyris; Athanasios Kotsakis; Nikolaos Androulakis; N Bahlitzanakis; Vassilis Georgoulias
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.
European journal of cancer (Oxford, England : 1990) 1998;34(6):838-44.
1998: F Guddo; Alexandra Giatromanolaki; Carlo Patriarca; J Hilkens; C Reina; R M Alfano; Antonio M Vignola; Michael I Koukourakis; M Gambacorta; Giancarlo Pruneri; Guido Coggi; Giovanni Bonsignore
Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progression.
Anticancer research 1998;18(3B):1915-20.
1998: Michael I Koukourakis; Alexandra Giatromanolaki; Stylianos Kakolyris; K J O'Byrne; N Apostolikas; J Skarlatos; K C Gatter; A L Harris
Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
British journal of cancer 1998;77(10):1696-703.
1998: Alexandra Giatromanolaki; Michael I Koukourakis
p53 and angiogenesis in non-small-cell lung cancer.
British journal of cancer 1998;77(5):850-2.
1998: LG Kaklamanis; Stylianos Kakolyris; Helen Turley; Michael I Koukourakis; SC Biddolph; Kevin C Gatter; Adrian L Harris
Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas.
Angiogenesis 1998;2(1):49-55.
1998: Alexandra Giatromanolaki; Michael I Koukourakis; Stylianos Kakolyris; LG Kaklamanis; K Barbatis; K J O'Byrne; D Theodosssiou; Adrian L Harris; Kevin C Gatter
Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer.
Anticancer research 1998;18(1A):71-6.
1997: Michael I Koukourakis; Alexandra Giatromanolaki; KJ O'Byrne; RM Whitehouse; Denis C Talbot; Kevin C Gatter; Adrian L Harris
Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer.
International journal of cancer. Journal international du cancer 1997;74(6):565-70.
1997: Alexandra Giatromanolaki; Michael I Koukourakis; D Theodossiou; K Barbatis; K O'Byrne; Adrian L Harris; Kevin C Gatter
Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2485-92.
1997: L Kosma; Michael I Koukourakis; J Skarlatos; C Zambatis; A Ardavanis; K Beroukas; D Yannakakis
Hypofractionated radiotherapy with 5-fluorouracil radiosensitization for locally "far advanced" breast cancer.
American journal of clinical oncology 1997;20(6):562-6.
1997: Michael I Koukourakis; Sophia Koukouraki; Alexandra Giatromanolaki; J Skarlatos; Vassilis Georgoulias; Nikolaos Karkavitsas
Non-small cell lung cancer functional imaging: increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):749-54.
1997: Alexandra Giatromanolaki; Michael I Koukourakis; M Comley; LG Kaklamanis; Helen Turley; K O'Byrne; Adrian L Harris; Kevin C Gatter
Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer.
The Journal of pathology 1997;181(2):196-9.
1997: Michael I Koukourakis; Alexandra Giatromanolaki; KJ O'Byrne; M Comley; RM Whitehouse; Denis C Talbot; Kevin C Gatter; Adrian L Harris
Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
British journal of cancer 1997;75(4):477-81.
1996: Alexandra Giatromanolaki; Michael I Koukourakis; K O'Byrne; LG Kaklamanis; C Dicoglou; E Trichia; RM Whitehouse; Adrian L Harris; K C Gatter
Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
Anticancer research 1996;16(6B):3819-25.
1996: Sophia Koukouraki; John Damilakis; Alexandra Giatromanolaki; E Androulakis; Nikolaos Karkavitsas; Michael I Koukourakis
Functional imaging of tumours with 99Tcm-sestamibi pinhole scintigraphy.
Nuclear medicine communications 1996;17(11):943-51.
1996: LG Kaklamanis; Michael I Koukourakis; Russell Leek; Alexandra Giatromanolaki; M Ritter; RM Whitehouse; K C Gatter; Adrian L Harris
Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.
British journal of cancer 1996;74(10):1627-31.
1996: Michael I Koukourakis; RM Whitehouse; Alexandra Giatromanolaki; M Saunders; LG Kaklamanis
Predicting distant failure in nasopharyngeal cancer.
The Laryngoscope 1996;106(6):765-71.
1996: Alexandra Giatromanolaki; Michael I Koukourakis; K O'Byrne; S Fox; RM Whitehouse; Denis C Talbot; Adrian L Harris; K C Gatter
Prognostic value of angiogenesis in operable non-small cell lung cancer.
The Journal of pathology 1996;179(1):80-8.
1996: Alexandra Giatromanolaki; V Gorgoulis; Runjan Chetty; Michael I Koukourakis; RM Whitehouse; Christos Kittas; Marinos Veslemes; K C Gatter; I Iordanoglou
C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
Anticancer research 1996;16(2):987-93.
1996: Michael I Koukourakis; G Hlouverakis; L Kosma; J Skarlatos; John Damilakis; Alexandra Giatromanolaki; D Yannakakis
The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma.
International journal of radiation oncology, biology, physics 1996;34(2):315-22.
1996: J Skarlatos; L Kosma; Michael I Koukourakis; C Zambatis; A Kapsoritakis; N Mouder; D Yannakakis
Hypofractionated radiotherapy with concurrent 5-fluorouracil radiosensitisation for recurrent or locally advanced colorectal cancer. A phase II study.
International journal of colorectal disease 1996;11(5):206-10.
1995: LG Kaklamanis; Russell Leek; Michael I Koukourakis; K C Gatter; Adrian L Harris
Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer.
Cancer research 1995;55(22):5191-4.
1995: John Damilakis; Michael I Koukourakis; A Hatjidakis; Spyros Karabekios; Nicholas Gourtsoyiannis
Radiation exposure to the hands of operators during angiographic procedures.
European journal of radiology 1995;21(1):72-5.
1995: Michael I Koukourakis; J Skarlatos; L Kosma; Alexandra Giatromanolaki; D Yannakakis
Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure.
Acta oncologica (Stockholm, Sweden) 1995;34(4):525-30.
1994: Michael I Koukourakis; John Damilakis
LQ-based model for biological radiotherapy planning.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1994;19(4):269-77.
1994: J Skarlatos; Michael I Koukourakis; H Zambatis; C Varveris; S Karvelas; N Tsopelas; D Yannakakis
Transurethral 137Cs medium dose rate radiotherapy as a boost for small-sized localized prostatic carcinomas.
Urologia internationalis 1994;53(4):209-13.
1994: Michael I Koukourakis; H Zambatis; J Skarlatos; I Stamatelatos; V Georgolopoulou; A Rebelakos; D Yannakakis
Transurethral radiotherapy for benign prostatic hypertrophy-related urethral obstruction. Dosimetry, ethics, and preliminary results.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1994;19(2):67-72.
1993: Michael I Koukourakis; J Scarlatos; D Yiannakakis; N Kordiolis; H Zambatis; A Sotiropoulou
High dose hyperfractionated radiotherapy for adults with glioblastomas.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1993;18(3):99-105.
1992: D Giannakakis; Michael I Koukourakis; A Sotiropoulou; H Zambatis; J Scarlatos
Accelerated hyperfractionation of radiotherapy for rapidly growing inoperable breast cancer unresponsive to chemotherapy.
Tumori 1992;78(5):326-9.